1.Construction of sharing type network resource data base for clinical skills teaching
Ailing HUI ; Dong HU ; Jian CHEN ; Lijun TANG ; Jinchun SI
Chinese Journal of Medical Education Research 2012;11(5):525-528
The construction of a network resource data base for clinical skill teaching aiming at sharing excellent teaching resources was completed by integrating all kinds of teaching resource including characters,eourseware,pictures,cartoons,videos and examination questions,etc.In view of the generally weak situation of the current domestic education resource data base construction,the contents,guiding ideology,principle,object,orientation,function and the management mechanism of the network resource data base construction were devised for clinical skills teaching.Suggestions for specific ideas and construction problems were proposed to promote the construction and optimization of the network resource database for clinical skills teaching.
2.Study on liver fibrosis of chronic hepatitis B with ultrasound tissue characterization
Hanying LI ; Changfeng DONG ; Ting HUANG ; Zhigang WANG ; Jinchun LIU
Chinese Journal of Ultrasonography 2003;0(07):-
Objective To study a kind of quantitative diagnosis method with ultrasound tissue characterization on liver fibrosis of the patients with chronic hepatitis B.Methods Measuring the gray scales of the two dimensional ultrasonography of the patients and compare the gray scales with the fibrosis degrees on histopathology of the patients and finding the differences among every two groups.Results The differences of the gray scales compared with the fibrosis degrees on histopathology were meaningful on statistics( F = 34.3, P
3.13C-methacetin breath test as a quantitative liver function assessment in non-alcoholic fatty liver
Juanjuan MENG ; Zhigang ZHANG ; Jinchun LIU ; Xiong YANG ; Zhiyong DONG ; Shuo YANG
Journal of Chinese Physician 2009;11(4):479-481
Objective To investigate and assess 13C-methacetin breath test as a method to quantitatively evaluate the liver function of non-alcoholic fatty liver. Methods Twenty-four male Wistar rats were randomly divided into the following 2 groups, control group given a standard chow and model group given high-fat diet (88 % standard chow + 10% lard +2% cholesterol). At the 8th week and 12th week, the isotope-selective nondispersive infrared spectrometer (NDIRS) was applied to 13C-methacetin breath test. Peak value of breathing (DOB), the duration to peak (T), and cumulative expiration within 60 min (CUM60min) were determined. Then, the two groups of rats were executed respectively. The level of endotoxin in the portal vein and abdominal aorta was detected respectively, and the specific tissue of liver was fixed in 10% buffered formalin, processed, and embedded in paraffin for hematoxylin eosin (H&E). Results Compared with the control group, DOB increased in the model group at the 12th week but not at the 8th week. The trend was corresponded to the degree of path-ological lesion in the liver of rats. At the 8th week and 12th week, endotoxin levels in the portal vein of model group were significantly in-creased compared with control group. The breath test results were positively related to emlotoxin levels in the portal vein. Conclusion 13C-methacetin breath test may be a non-invasive method to evaluate the pathological changes of non-alcoholic fatty liver.
4.Effect of Fructus Mume Extract on Repair of Renal Injury Induced by Nanobacteria in Rats and Its Relationship with Antagonistic Stone Formation
Jianfeng XIA ; Jiang GU ; Yongchun ZHANG ; Miao LIU ; Antao DONG ; Jinchun YANG
Journal of China Medical University 2017;46(7):640-644
Objective To observe the early effect of Fructus mume extract on KIM-1 and OPN levels in rats with kidney stone formation induced by nanobacteria and to investigate the therapeutic significance of F.mume extract on early kidney stone formation.Methods Nanobacteria were separated and cultured from human upper urinary calculi.The study group appropriately included 54 healthy male SD rats.The renal calculus model was constructed by tail vein injection of nanobacteria.A kidney stone model was created with an F.mume extract intervention,and rats were killed at different stages of the intervention.Real-time polymerase chain reaction was used to detect the KIM-1 mRNA expression in rat renal tissue,and the KIM-1 concentration in urine was detected by using enzyme-linked immunosorbent assay.We detected kidney tissue stone crystals and OPN expression by using hematoxylin-eosin staining and immunohistochemistry.Results Renal tubules of the experimental model were significantly expanded,that is,the formation of renal tubular stones.The early KIM-1 and OPN expression levels were increased.The above-mentioned changes positively correlated with the injection time of the nanobacteria,and F.mume extract antagonized the changes.Conclusion F.mume extract may be useful for the repair of renal injury to reduce kidney stone formation,which may be related to the gene regulation of KIM-1 and OPN.
5.Effects of intravenous dexmedetomidine combined with lidocaine on inflammatory cytokines after abdomi-nal hysterectomy under general anesthesia
Jinchun DONG ; Shengbin WANG ; Siqi XU ; Ye ZHANG
The Journal of Practical Medicine 2018;34(5):820-823,827
Objective To evaluate the effects of dexmedetomidine combined with lidocaine on postopera-tive cytokine response after abdominal hysterectomy. Methods We enrolled 80 women with American Society of Anesthesiologists(ASA)physical statusⅠandⅡ,aged 35-68,and scheduled for elective abdominal hysterectomy under general anesthesia.The patients were randomly assigned into CON group,LIDO group,DEX group and LI-DO + DEX group(n=25 in each group). The four groups received an Ⅳ bolus infusion of normal saline,lido-caine,dexmedetomidine,and lidocaine combined with dexmedetomidine respectively,over 10 minutes before in-duction of anesthesia,followed by a continuous IV infusion of normal saline,lidocaine,dexmedetomidine,and li-docaine combined with dexmedetomidine until abdominal wound closure,respectively.Interleukin-6 and tumor ne-crosis factor-α levels in serum were measured before administration of drugs(T1),at the end of surgery(T2),post-operative 2 hour(T3)and postoperative 24 hour(T4). Results Interleukin-6 and tumor necrosis factor-α level in serum were higher at T2,T3and T4in the four groups. Compared to those in CON group,interleukin-6 and tumor necrosis factor-α levels in DEX and DEX+LIDO group were significantly decreased at T2,T3and T4(P<0.05). Interleukin-6 and tumor necrosis factor-α level in serum in LIDO group were also decreased at T2,T3and T4,but there was no significant difference between CON group and LIDO group(P > 0.05). Compared to that in LIDO group,tumor necrosis factor-α level in serum in DEX group was significantly decreased at T3and T4;interleukin-6 level in serum in DEX group was significantly decreased at T2,T3and T4(P<0.05).Interleukin-6 and tumor ne-crosis factor-α levels in serum in DEX+LIDO group were the lowest compared to those in other three groups at T2,T3and T4(P < 0.05). Recovery time and extubation time were significantly prolonged between DEX group and DEX + LIDO group(P < 0.05). Conclusions Dexmedetomidine combined with lidocaine infusion significantly decrease postoperative cytokine response and this may be attributed to the anti-inflammation effects of dexmedetomi-dine and lidocaine.
6.Ideas and Briefing about Regulatory Requirements for Laboratory Developed Tests in the US.
Zhaozhao HAN ; Yang ZHAO ; Yunfeng L ; Jinchun DONG ; Gang DENG
Chinese Journal of Medical Instrumentation 2022;46(5):534-537
As a special kind of in vitro diagnostic devices(IVDs), laboratory developed tests(LDTs) are of great significance to the development of clinical laboratories. This study aims to explore the regulatory requirements ideas of LDTs. By introducing the development of LDTs and the changing of regulatory requirements in the United States, combing the current regulatory framework and discussing relevant ideas in the regulatory requirements of LDTs.
Clinical Laboratory Services
;
Laboratories
;
Reagent Kits, Diagnostic
;
United States
;
United States Food and Drug Administration